In-Vitro Test Results

Our laboratory test results (that were done in a Biosecurity Level 3 laboratory) and early clinical data, demonstrate not only immediate inactivation of the coronavirus but also single dosage inactivation of MDR MRSA, Pseudomonas aeruginosa, Acinetobacter baumannii, CRE (including OXA-48 K. pneumoniae, Candida parapsilosis, C albicans and C auris, Trichophyton interdigitale, Cutibacterium. acnes and Mycobacterium tuberculosis (drug-resistant and drug-sensitive) and has powerful anti-biofilm and anti-inflammatory action, which is often the cause of death in these infections. The potential clinical benefit of a new, safe, and effective treatment of both these lung diseases holds tremendous promise for those suffering from these conditions.

Our in vitro cytotoxicity results from a laboratory in Eagen, MN USA also confirmed no toxicity in the human lung cells that were used to conduct our coronavirus studies. The lack of any form of toxicity has also been demonstrated in further studies, which has now opened the way to full-blown clinical trials.